Developing Biosimilars to Drive Down Costs and Incentivize Innovation with Ming Li Alvotech TRANSCRIPT
Download PDFNov 8, 2022
Ming Li is the Chief Strategy Officer at Alvotech, a biosimilar-only company developing biosimilar drugs to provide lower-cost alternatives in the global marketplace. Biosimilars are analogous to generic medicines, but these drugs are complex molecules developed and produced out of living systems, requiring...
Nov 8, 2022
Ming Li is the Chief Strategy Officer at Alvotech, a biosimilar-only company developing biosimilar drugs to provide lower-cost alternatives in the global marketplace. Biosimilars are analogous to generic medicines, but these drugs are complex molecules developed and produced out of living systems, requiring...
Partners in the Continuum of Drug Development with Gabriele Brambilla AliraHealth TRANSCRIPT
Download PDFJul 27, 2022
Gabriele Brambilla is the CEO and Executive VP of AliraHealth and is looking for ways to humanize healthcare and involve patients in the entire drug development continuum. They deliver services to drug developers, medical device developers, and digital health solution providers.
Gabriele explains, "We call it...
Jul 27, 2022
Gabriele Brambilla is the CEO and Executive VP of AliraHealth and is looking for ways to humanize healthcare and involve patients in the entire drug development continuum. They deliver services to drug developers, medical device developers, and digital health solution providers.
Gabriele explains, "We call it...
Getting Across Tissue Barriers for Precise Delivery of Drugs with Jeff Cleland Ashvattha Therapeutics TRANSCRIPT
Download PDFJul 13, 2022
Jeff Cleland is the Chairman, President, and CEO of Ashvattha Therapeutics, initially focusing on demonstrating the ability to deliver drugs that cross tissue barriers like the blood-brain barrier and the blood-retinal barrier to attack inflammation. The company is part of the emerging era of Hydroxyl Dendrimer...